RxDoctor Payments Data

Emily Jensen

Medical · Bowling Green, MONPI 1528542966

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $41,540 of the $51,402 with a category attached, or 80.8%. AbbVie accounts for 97.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $45,741 and has fallen 99.1% since, to $407 in 2025. Among medical clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,402in general payments, 2019–2025

Across 176 payments — averaging $292.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$50K
  • Amgen$315
  • Lilly USA, LLC$243
  • Merz North America, Inc.$174
  • Novo Nordisk$168
  • AstraZeneca$67
  • plus $504 from 14 others

What the payments were for

  • Speaking & faculty fees$41,54081%
  • Travel & lodging$6,75413%
  • Food & beverage$3,1096%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,402 in reported general payments places this provider in the 95th percentile of 198 medical providers in Missouri.

See all medical providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$68,347
VraylarCariprazine Hcl31$50,326
TrulicityDulaglutide28$30,993
FarxigaDapagliflozin Propanediol27$22,961
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl29$4,918
Insulin Lispro Kwikpen U-100Insulin Lispro17$2,903
Vilazodone Hcl13$1,995
Albuterol Sulfate HfaAlbuterol Sulfate53$1,023
Gabapentin47$970
Buspirone Hcl43$885
Losartan Potassium105$858
Potassium Chloride35$770
Desvenlafaxine Succinate ErDesvenlafaxine Succinate12$654
Omeprazole44$647
Duloxetine Hcl16$441

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$168$68,34758 claims
AbbVieVraylar$49,931$50,32631 claims
Lilly USA, LLCTrulicity$243$30,99328 claims
AstraZenecaFarxiga$67$22,96127 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 198 medical providers in Missouri.

Other medical in Bowling Green

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →